Pharmaceutical Robots Market by Product Type, Distribution Channel, End User 2024-2032


MARKETRESEARCH

Uploaded on May 3, 2024

According to the latest research report by IMARC Group, The global pharmaceutical robots market size reached US$ 198.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 445.0 Million by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. More Info:- https://www.imarcgroup.com/pharmaceutical-robots-market

Comments

                     

Pharmaceutical Robots Market by Product Type, Distribution Channel, End User 2024-2032

Global Pharmaceutical Robots Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A cc o r d i ng t o t h e l a t e s t r e p o r t b y IM A R C Gr o u p , t i t l e d " P h a r m ac e u t i c a l R o b o t s Ma r k e t : G l o b a l In d u s t r y T r e n d s , S h a r e , S i ze , G r o w t h , O p p o r t u n i ty a n d F o r e c a s t 20 2 4 - 2 03 2 , " t h e g l ob a l p ha r m a ce u t i c a l r o b o t s ma r ke t s i z e re a c h e d U S $ 19 8 . 5 M i l l i o n i n 20 2 3 . Report P ha r m ac e u t i c a l r ob o t s a r e p h y s i ca l l y em b o d i e d a r t i f i c i a l i n t e l l i g e n c e ( A I ) a g e n ts de s i g n e d t o pe r f o rm r ou t i n e t a s k s , e l i m i na t i n g t h e n e e d f o r h u ma n i n t e rv en t i o n . T h e y he l p a u t om a t e va r i o u s f u n c t i o n s , i n c l ud i n g i n sp e c t i o n , p a c ka g i n g , d i sp e n s i n g , d r u g Highlight and so r t i n g , k i t a s s e mb l y , a nd l i g h t m a c h i n e - t e nd i n g . T h e y a l s o a i d i n t h e p r o du c t i o n o f cu s t o m i ze d me d i c i n e s , r e d uc i n g w o r k l o a ds , a nd p r e ve n t i n g d r u g co n t a m i n a t i o n . B es i d e s t h i s , t h e y a ss i s t i n i m p ro v i n g p r o d u c t i v i t y , en s u r i ng c o n s i s t e n cy , m i n i m i z i n g Description do w n t i m e , e n h a nc i n g f l e x i b i l i t y , an d s pe e d i n g up p r o c e ss e s . A s a r e s u l t , ph a r m a ce u t i c a l r o b o ts a re g a i n i n g i m m e ns e t r a c t i on a c r o s s t h e p h a r ma c e u t i c a l i nd u s t r y as t h e y o f fe r m a x i m u m e f f i c i e n cy , p r o t ec t w o r ke r s f r o m h az a r d o us e n v i r on m e n t s , a nd cu t c o s ts . R eq u e s t f o r a P D F sa m p le o f th i s r ep o r t : h t t p s : / /w w w . i ma r c g r o u p . co m / p ha r m a ce u t i c a l - r o b o ts - m a r k e t / r eq u e s ts a m p l e Report Description G l o b a l P h a r m a c e u t i c a l R o b o t s M a r k e t T r e n d s : T h e s u r g i n g n e e d f o r a u t o m a t i o n i n m a n u f a c t u r i n g u n i t s r e p r e s e n t s t h e p r i m a r y f a c t o r d r i v i n g t h e m a r k e t g r o w t h . M o r e o v e r , t h e s i g n i f i c a n t e x p a n s i o n i n t h e p h a r m a c e u t i c a l s e c t o r a n d t h e i n c r e a s i n g c o m p e t i t i o n h a v e p r o m p t e d d r u g m a n u f a c t u r e r s t o a d o p t p h a r m a c e u t i c a l r o b o t s a s t h e y e n h a n c e s a f e t y , r e l i a b i l i t y , a n d f i n a n c i a l s a v i n g s . A l o n g w i t h t h i s , t h e h i g h c o s t s o f n e w d r u g d i s c o v e r y h a v e a u g m e n t e d t h e d e m a n d f o r r o b o t s i n c l i n i c a l t r i a l s , d r u g d i s c o v e r y , a n d l a b o r a t o r i e s f o r a u t o m a t i n g p r o c e d u r e s . B e s i d e s t h i s , t h e r i s i n g p r e f e r e n c e s f o r p e r s o n a l i z e d m e d i c i n e t h a t r e q u i r e s c u s t o m i z e d m e d i c a t i o n s , p a c k a g i n g , a n d l a b e l i n g h a v e a c c e l e r a t e d p r o d u c t a d o p t i o n r a t e s . A d d i t i o n a l l y , t h e r e h a s b e e n a s u b s t a n t i a l i n c r e a s e i n t h e d e m a n d f o r s p e c i f i c p a c k a g i n g c o n f i g u r a t i o n s a n d o t h e r b e n e f i t s , s u c h a s h i g h s p e e d , p r e c i s i o n , o p t i m a l u t i l i z a t i o n o f s p a c e , a n d z e r o e r r o r o p e r a t i o n s . I n l i n e w i t h t h i s , v a r i o u s t e c h n o l o g i c a l a d v a n c e m e n t s , s u c h a s t h e i n t e g r a t i o n o f a r t i f i c i a l i n t e l l i g e n c e ( A I ) i n r o b o t i c s , h a v e c a t a l y z e d m a r k e t g r o w t h . F u r t h e r m o r e , t h e l e a d i n g p l a y e r s a r e e n g a g i n g i n r e s e a r c h a n d d e v e l o p m e n t ( R & D ) a c t i v i t i e s t o l a u n c h c o l l a b o r a t i v e r o b o t s . A p a r t f r o m t h i s , d u e t o r i s i n g d r u g d i s c o v e r y a n d d i a g n o s t i c t e s t i n g , t h e e m e r g i n g l a b o r a t o r y a p p l i c a t i o n s o f p h a r m a c e u t i c a l r o b o t s l i k e v i a l h a n d l i n g t o m i n i m i z e t h e r i s k s o f h u m a n c o n t a m i n a t i o n h a v e p r o p e l l e d m a r k e t g r o w t h . O t h e r f a c t o r s , i n c l u d i n g t h e s u r g i n g p r o d u c t a d o p t i o n i n q u a l i t y c o n t r o l a n d i n s p e c t i o n o f p h a r m a c e u t i c a l d r u g s , l a c k o f s k i l l e d l a b o r , a n d i n c r e a s i n g m e r g e r a n d a c q u i s i t i o n ( M & A ) a c t i v i t i e s a m o n g k e y p l a y e r s , a r e a l s o c r e a t i n g a f a v o r a b l e m a r k e t o u t l o o k . L o o k i n g f o r w a r d , I M A R C G r o u p e x p e c t s t h e m a r k e t v a l u e t o r e a c h U S $ 4 4 5 . 0 M i l l i o n b y 2 0 3 2 , g r o w i n g a t a C A G R o f 9 . 2 % d u r i n g 2 0 2 4 - 2 0 3 2 . V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / p h a r m a c e u t i c a l - r o b o t s - m a r k e t Breakup by Type: • Tradit ional Robots o Art iculated Robots o SCARA Robots o Delta/Paral lel Robots o Cartesian Robots o Dual-arm Robots Report • Col laborative Pharmaceutical Robots Segmentation   Breakup by Application: • Picking and Packaging • Inspect ion of Pharmaceutical Drugs • Laboratory Appl icat ions Breakup by End User: • Pharmaceutical Companies • Research Laboratories Breakup by Region: • North America • Asia-Pacifi c • Europe Report • Latin America Segmentation • Middle East and Afr ica • ABB Ltd. • DENSO Corporat ion • FANUC Corporation • Kawasaki Heavy Industr ies Ltd. Competitive • Kuka AG Landscape • Marchesini Group S.p.A with Key • Mitsubishi Electr ic Corporation • Robert Bosch GmbH Players • Seiko Epson Corporat ion • Shibuya Corporation • Universal Robots A/S (Teradyne Inc.) • Yaskawa Electric Corporation What was the size of the global pharmaceutical robots market in 2023? What is the expected growth rate of the global pharmaceutical robots market during 2024-2032? What are the key factors driving the global pharmaceutical robots market? Key What has been the impact of COVID-19 on the global pharmaceutical robots market? Questions What is the breakup of the global pharmaceutical Answered in robots market based on the type? the Report What is the breakup of the global pharmaceutical robots market based on the application? What is the breakup of the global pharmaceutical robots market based on the end user? What are the key regions in the global pharmaceutical robots market? Who are the key players/companies in the global pharmaceutical robots market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l P h a r m a c e u t i c a l R o b o t s M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y T y p e 6 . 1 T r a d i t i o n a l R o b o t s 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 K e y S e g m e n t s 6 . 1 . 2 . 1 A r t i c u l a t e d R o b o t s 6 . 1 . 2 . 2 S C A R A R o b o t s 6 . 1 . 2 . 3 D e l t a / P a r a l l e l R o b o t s 6 . 1 . 2 . 4 C a r t e s i a n R o b o t s 6 . 1 . 2 . 5 D u a l - a r m R o b o t s 6 . 1 . 3 M a r k e t F o r e c a s t 6 . 2 C o l l a b o r a t i v e P h a r m a c e u t i c a l R o b o t s 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y A p p l i c a t i o n 7 . 1 P i c k i n g a n d P a c k a g i n g 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 I n s p e c t i o n o f P h a r m a c e u t i c a l D r u g s 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t Table of 7 . 3 L a b o r a t o r y A p p l i c a t i o n s 7 . 3 . 1 M a r k e t T r e n d s 7 . 3 . 2 M a r k e t F o r e c a s t 8 M a r k e t B r e a k u p b y E n d U s e r Contents 8 . 1 P h a r m a c e u t i c a l C o m p a n i e s 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t 8 . 2 R e s e a r c h L a b o r a t o r i e s 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 9 M a r k e t B r e a k u p b y R e g i o n 9 . 1 N o r t h A m e r i c a 9 . 1 . 1 U n i t e d S t a t e s 9 . 1 . 1 . 1 M a r k e t T r e n d s 9 . 1 . 1 . 2 M a r k e t F o r e c a s t         9 . 1 . 2 C a na da             9 . 1 .2 .1 Ma rke t Trends             9 . 1 .2 .2 Ma rke t Fo rec a s t F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /p ha rm a c eut i c a l - ro bo t s -m a rke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]